AXCELON BIOPOLYMERS CORPORATION

Axcelon Biopolymers Corporation is an innovative biomaterials company focused on leveraging its unique Bacterial NanoCellulose (BNC) platform technology to develop bacterial cellulose-based, high value products for wound care, medical devices, and industrial applications... Axcelon is unique among early stage medical device companies. The Company is positioned to generate attractive near-term revenues from a licensed ready-to-market product and has impressive mid and long-term prospects for developing innovative and proprietary materials from its platform technology. This healthy combination will enable Axcelon to leverage the revenues and experience gained in the near-term to fully exploit the Company's significant long-term prospects... 1. Axcelon Dermacare Inc. - Commercial wound care division now selling Nanoderm™, a high clinical impact and cost effective wound care product, with a follow-on product launch (Nanoderm™Ag) in 2017

Also known as: Axcelon, Axcelon Biopolymers, Axcelon Biopolymers Corp., Axcelon Dermacare Inc.

Primary location: London